September 9, 2014

Sanofi Pasteur announced that the Food and Drug Administration approved the use of Menactra [meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine] as a booster vaccination against meningococcal disease in people ages 15 years through 55 years. 

July 30, 2014

The American Academy of Pediatrics has updated its recommendations on the use of meningococcal vaccines in children and adolescents, according to the online issue of Pediatrics.

June 17, 2014

Novartis on Tuesday announced that it had submitted a biologic license application to the Food and Drug Administration for marketing approval for the use of Bexsero.

February 5, 2014

The Centers for Disease Control and Prevention published an updated "Immunization Schedule for Adults Aged 19 Years or Older, 2014," in the Morbidity and Mortality Weekly Report.

December 9, 2013

Swiss drug maker Novartis is providing a vaccine to Princeton University amid an outbreak of potentially fatal meningitis that has affected at least eight students, the university said Monday.

August 2, 2013

The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

June 13, 2013

Voices of Meningitis, a public health initiative of the National Association of School Nurses, in collaboration with Sanofi Pasteur, has announced the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease.

November 7, 2011

CVS Caremark’s MinuteClinic has prepared all of its Texas-based clinics for an increased demand for the meningococcal vaccine for bacterial meningitis following a bill signed into law last May, whereby Texas will become the first state in the country to require that all college students receive one dose or booster of the meningococcal vaccine for bacterial meningitis.

April 25, 2011

The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

October 25, 2010

An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in...

August 25, 2010

The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the...